Department of Public Health Sciences
|Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment
Mufson, EJ, EY Chen, EJ Cochran, LA Beckett, DA Bennett and JH Kordower
Exp. Neurol.. 1999. 158(2):469-490.
The deposition of beta-amyloid within the entorhinal cortex (EC) may play a key role in the development of mild cognitive impairment (MCI) in the elderly. To examine the relationship of beta-amyloid deposition to MCI, EC tissue immunostained for this protein was quantitated from a cohort of aged Catholic religious clergy with a clinical diagnosis of MCI and compared to those with no cognitive impairment (NCI) and Alzheimer's disease (AD). beta-amyloid staining was seen in 12 of the 20 NCI, in 10 of 12 MCI, and in all 12 AD cases within the EC. p- amyloid immunoreactivity displayed two patterns within the EC: (1) a crescent-shaped band within layers 3-4 or (2) bilaminar staining mainly within layers 2-3 and 5-6. Ten cases failed to display any detectable beta-amyloid imunoreactivity. Despite the heterogeneity of beta-amyloid loads within the clinical groups, decomposing an analysis of variance revealed a significant difference across groups in mean beta-amyloid load within the EC based upon a linear trend analysis. Multiple comparisons testing revealed that NCI individuals had a significantly lower mean beta-amyloid load (1.32) than AD individuals (4.55). The MCI individuals had a mean intermediate (2.60) load be tween NCI and AD, but not statistically distinguishable from the mean for either NCI or AD. Spearman rank correlation showed a trend for decreasing MMSE with increasing amyloid load that failed to reach statistical significance. Since many NCI cases displayed beta-amyloid loads equal to or greater than that seen in some MCI and some AD cases, it is mostly likely that deposition of this protein is not the sole pathogenic event underlying cognitive impairment in the elderly. (C) 1999 Academic Press.
Keywords: amyloid; aging; dementia; cortex; histochemistry; plaques; tangles, Alzheimers-disease Cerad; Apolipoprotein-e; Memory Impairment; Transgenic Mice; Pathological-changes; Senile Plaques; Neurofibrillary Tangles; Nondemented Subjects; Parkinsons- Disease; Precursor Protein
UC Davis Health System is pleased to provide this information for
general reference purposes only. It should not be considered as
a substitute for professional medical advice. You are urged to consult
with your health care provider for diagnosis of and treatment for
any health-related condition. The information provided herein may
not and should not be used for diagnosis and treatment.
Reproduction of material on this web site is hereby granted solely
for personal use. No other use of this material is authorized without
prior written approval of UC Regents.